Here is a detailed article about Sumitomo Pharma’s announcement regarding financial expenses (foreign exchange losses), presented in a polite tone with relevant information: Sumitomo Pharma Reports on Recognition of Financial Expenses (Foreign Exchange Losses) Osaka, Japan – July 31, 2025 – Sumitomo Pharma Co., Ltd. (hereinafter referred to as “the Company”) today announced the recognition … Read more
Here is a detailed article about Sumitomo Pharma’s Q1 FY2026 financial results, presented in a polite tone: Sumitomo Pharma Reports First Quarter Fiscal Year 2026 Financial Results Tokyo, Japan – July 31, 2025 – Sumitomo Pharma Co., Ltd. today announced its financial results for the first quarter of the fiscal year ending March 31, 2026. … Read more
Here is an article detailing Sumitomo Pharma’s Q1 FY2025 results, presented in a polite and informative manner: Sumitomo Pharma Reports Q1 FY2025 Financial Results, Highlighting Strategic Progress Sumitomo Pharma Co., Ltd. released its supplementary financial information for the first quarter of fiscal year 2025 (ending March 31, 2026) on July 31, 2025. The report provides … Read more
Here is an article detailing Sumitomo Pharma’s Q1 FY2025 results, based on the provided document: Sumitomo Pharma Reports Q1 FY2025 Financial Results, Highlighting Strategic Advancements Osaka, Japan – July 31, 2025 – Sumitomo Pharma Co., Ltd. today announced its financial results for the first quarter of the fiscal year 2025, which concluded on June 30, … Read more
Sumitomo Pharma’s Novel TLR7 Vaccine Adjuvant Selected for CEPI Adjuvant Library, Signaling Hope for Pandemic Preparedness Sumitomo Pharma Co., Ltd. announced on July 31, 2025, with significant implications for global health security, that its novel Toll-like receptor 7 (TLR7) vaccine adjuvant has been selected for inclusion in the Coalition for Epidemic Preparedness Innovations (CEPI) Adjuvant … Read more
Sumitomo Pharma Releases Q1 FY2025 Earnings Presentation Audio Tokyo, Japan – August 1, 2025 – Sumitomo Pharma Co., Ltd. (hereinafter referred to as “Sumitomo Pharma”) has announced the release of an audio recording of its earnings presentation for the first quarter of fiscal year 2025 (ending March 31, 2026). The audio material, providing insights into … Read more
Nomura Securities Reports First Quarter Results for Fiscal Year Ending March 2026 Tokyo, Japan – July 29, 2025 – Nomura Securities, a leading global financial services group, today announced its financial results for the first quarter of the fiscal year ending March 31, 2026. The company reported a solid performance, demonstrating resilience and strategic progress … Read more
Nomura Securities Reports Strong Q1 Performance Driven by Robust Business Activities Tokyo, Japan – July 29, 2025 – Nomura Holdings, Inc. today announced its consolidated financial results for the first quarter of the fiscal year ending March 31, 2026. The company reported a solid performance, exceeding expectations and demonstrating the resilience and strength of its … Read more
Nomura Securities Extends Comprehensive Support to the 25th Summer Deaflympics Tokyo 2025 Tokyo, Japan – August 1, 2025 – Nomura Holdings, Inc. (Nomura) is pleased to announce its commitment as a Total Support Member for the upcoming 25th Summer Deaflympics Tokyo 2025. This significant partnership underscores Nomura’s dedication to fostering an inclusive society and supporting … Read more
Trade Agreements Signal Stability, Minimal Freight Disruption Expected for Now Freightos.com – July 29, 2025 In a move that is being cautiously welcomed by the global logistics sector, a series of recent trade agreements are anticipated to bring a period of welcome stability to international trade flows. While the immediate impact on freight operations is … Read more